Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Steatohepatitis
100%
Liver Disease
18%
Diabetes
18%
Diabetes Mellitus
18%
Steatosis
18%
Pathogenesis
18%
Insulin Resistance
9%
Liver Cirrhosis
9%
Hyperlipidemia
9%
Liver Biopsy
9%
End Stage Liver Disease
9%
Hepatocellular Carcinoma
9%
Pioglitazone
9%
Insulin Sensitizing Agent
9%
Controlled Clinical Trial
9%
Alpha Tocopherol
9%
Clinical Research
9%
Placebo
9%
Diseases
9%
Gastrointestinal Disease
9%
Nephropathy
9%
Inflammation
9%
Obesity
9%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Liver Disease
18%
Steatosis
18%
Diabetes Mellitus
18%
Pathogenesis
18%
Insulin Sensitizing Agent
9%
End Stage Liver Disease
9%
Liver Cell Carcinoma
9%
Controlled Clinical Trial
9%
Liver Cirrhosis
9%
Alpha Tocopherol
9%
Clinical Research
9%
Placebo
9%
Hyperlipidemia
9%
Kidney Disease
9%
Pioglitazone
9%
Inflammation
9%
Insulin Resistance
9%
Gastrointestinal Disease
9%
Diseases
9%
Obesity
9%